Strong positive interim data from an earlier Phase 3 trial has led to early cessation of Merck’s pulmonary arterial ...
CT scan-assessed high right ventricle-left ventricle ratio of the heart predicts major adverse cardiovascular events in PH ...
Investigators used 4D flow cardiovascular magnetic resonance imaging to search for differences between pulmonary artery (PA) ...
As a child, Chris Kidwell had two surgeries to fix a heart defect. When he learned his son also had a heart defect, doctors ...
The abnormal accumulation of extravascular fluid, pulmonary edema settles in the lung interstitium and alveoli. There, it ...
Pulmonary arterial hypertension (PAH) can be a challenging complication to manage during pregnancy; women with PAH who are ...
A new program in the Central Valley is now offering much-needed treatments for patients suffering from an advanced form of lung disease called pulmonary ...
The leading Pulmonary Arterial Hypertension Companies such as Merck Sharp & Dohme, Acceleron Pharma, Liquidia Technologies, ...
Highlight box Key findings • The bibliometric analysis summarized the major areas and promising research directions on chronic thromboembolic pulmonary hypertension (CTEPH) over the past two decades.